Document is current
Any future updates will be listed below
-
Authors
Bednarik, Petr https://orcid.org/0000-0002-8828-7661
Goranovic, Dario
Svatkova, Alena https://orcid.org/0000-0002-9188-4280
Niess, Fabian
Hingerl, Lukas https://orcid.org/0000-0003-1808-8349
Strasser, Bernhard https://orcid.org/0000-0001-9542-3855
Deelchand, Dinesh K.
Spurny-Dworak, Benjamin
Krssak, Martin
Trattnig, Siegfried
Hangel, Gilbert https://orcid.org/0000-0002-3986-3159
Scherer, Thomas https://orcid.org/0000-0003-4980-706X
Lanzenberger, Rupert https://orcid.org/0000-0003-4641-9539
Bogner, Wolfgang https://orcid.org/0000-0002-0130-3463
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation (27238)
EC | Horizon 2020 Framework Programme (846793)
EC | Horizon 2020 Framework Programme (794986)
Austrian Science Fund (KLI 782)
Austrian Science Fund (KLI 646)
Austrian Science Fund (P 30701)
Austrian Science Fund (KLI718)
- License Information
-
More Information
Article History
Received: 28 October 2021
Accepted: 30 March 2023
First Online: 27 April 2023
Competing interests
: R. Lanzenberger received travel grants and/or conference speaker honoraria within the past three years from Bruker BioSpin MR and Heel, and has served as a consultant for Ono Pharmaceutical. He also received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR and is a shareholder of the start-up company BM Health GmbH since 2019. The other authors declare no competing interests.
